APYX MEDICAL CORPORATION's ticker is APYX and the CUSIP is 03837C106. A total of 56 filers reported holding APYX MEDICAL CORPORATION in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,114,283 | +23.1% | 1,775,793 | 0.0% | 0.60% | +38.5% |
| Q4 2022 | $4,155,355 | -67.6% | 1,775,793 | -37.8% | 0.43% | -64.6% |
| Q3 2022 | $12,818,000 | -22.4% | 2,854,841 | +1.3% | 1.23% | -23.1% |
| Q2 2022 | $16,515,000 | -4.0% | 2,818,341 | +7.0% | 1.60% | -3.7% |
| Q1 2022 | $17,200,000 | -29.5% | 2,634,003 | +38.5% | 1.66% | -25.1% |
| Q4 2021 | $24,384,000 | -6.3% | 1,902,003 | +1.2% | 2.21% | +79.4% |
| Q3 2021 | $26,024,000 | +62.5% | 1,879,003 | +21.0% | 1.23% | +47.5% |
| Q2 2021 | $16,013,000 | +217.5% | 1,553,199 | +197.5% | 0.84% | +140.9% |
| Q1 2021 | $5,043,000 | +39.2% | 522,042 | +3.8% | 0.35% | +7.1% |
| Q4 2020 | $3,622,000 | +58.8% | 503,081 | +3.9% | 0.32% | -12.9% |
| Q3 2020 | $2,281,000 | -9.3% | 484,246 | +6.8% | 0.37% | -11.0% |
| Q2 2020 | $2,516,000 | +97.5% | 453,298 | +27.7% | 0.42% | +42.7% |
| Q1 2020 | $1,274,000 | -36.2% | 354,879 | +50.4% | 0.29% | +69.4% |
| Q4 2019 | $1,996,000 | – | 235,986 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Archon Capital Management LLC | 3,452,030 | $11,046,496 | 2.90% |
| AIGH Capital Management LLC | 1,895,231 | $6,064,739 | 2.87% |
| Taylor Frigon Capital Management LLC | 621,147 | $1,987,670 | 1.10% |
| Worth Venture Partners, LLC | 462,606 | $1,480,339 | 0.88% |
| PERKINS CAPITAL MANAGEMENT INC | 211,800 | $678 | 0.67% |
| PURA VIDA INVESTMENTS, LLC | 836,990 | $2,678,368 | 0.51% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 372,106 | $1,190,739 | 0.19% |
| GREENWOOD CAPITAL ASSOCIATES LLC | 301,809 | $965,789 | 0.14% |
| RTW INVESTMENTS, LP | 1,777,194 | $5,687,021 | 0.12% |
| Legato Capital Management LLC | 140,062 | $448,198 | 0.06% |